InnovAge Holding Corp. Equity Method Investment, Realized Gain (Loss) on Disposal
InnovAge Holding Corp. (INNV) reported Equity Method Investment, Realized Gain (Loss) on Disposal of -$1.39 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-09.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2025-09-09
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for the quarter ending 2025-06-30 was -$1.39M, a 128.77% decline year-over-year.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for the quarter ending 2025-03-31 was $0.00.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for the quarter ending 2024-06-30 was $4.84M.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for the quarter ending 2024-03-31 was -$118.00K.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for fiscal 2025 was -$1.39M, a 149.01% decline from fiscal 2024.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for fiscal 2024 was $2.84M.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for fiscal 2023 was $0.00.
- InnovAge Holding Corp. equity method investment, realized gain (loss) on disposal for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 3 month | Equity Method Investment, Realized Gain (Loss) on Disposal 6 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$1.39M derived: sum of 2 quarters · filed 2025-09-09 | -$1.39M 10-K · filed 2025-09-09 | |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $0.00 10-Q · filed 2025-05-06 | ||
| 2024-12-31 | $0.00 10-Q · filed 2025-02-04 | |||
| 2024-06-30 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $4.72M derived: sum of 2 quarters · filed 2025-09-09 | $2.84M 10-K · filed 2025-09-09 | |
| 2024-03-31 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | -$2.00M 10-Q · filed 2025-05-06 | ||
| 2023-12-31 | -$1.88M 10-Q · filed 2025-02-04 | |||
| 2023-06-30 | $0.00 10-K · filed 2024-09-10 | |||
| 2022-06-30 | $0.00 10-K · filed 2023-09-12 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $10.87M derived: sum of 2 quarters · filed 2022-09-13 | $10.87M 10-K · filed 2022-09-13 | |
| 2021-03-31 | $10.87M 10-Q · filed 2022-05-10 | $10.87M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |